Citations (149)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Takahisa Gono & Masataka Kuwana. (2023) New paradigm in the treatment of myositis-associated interstitial lung disease. Expert Review of Respiratory Medicine 17:5, pages 397-411.
Read now
Read now
Satoshi Suzuki, Keigo Ikeda, Ken Yamaji, Naoto Tamura & Shinji Morimoto. (2021) Recurrence in long-term survivor of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis: case series and literature review. Modern Rheumatology Case Reports 5:2, pages 310-316.
Read now
Read now
Noriko Sasaki, Akira Ishii, Takayoshi Kurabayashi, Mai Sugiyama, Yuto Izumi, Yoko Nakagome, Kazuki Hirano, Sho Sasaki, Yasushi Kondo, Shinichi Nogi, Ayumi Nishikawa, Yuji Hosono, Chiho Yamada & Shinji Sato. (2021) Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease. Modern Rheumatology Case Reports 5:1, pages 87-94.
Read now
Read now
Fahidah M Alenzi. (2020) Myositis Specific Autoantibodies: A Clinical Perspective. Open Access Rheumatology: Research and Reviews 12, pages 9-14.
Read now
Read now
Takahisa Gono & Masataka Kuwana. (2020) Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis. Expert Review of Clinical Immunology 16:1, pages 79-89.
Read now
Read now
Aki Nishioka, Shinichiro Tsunoda, Takeo Abe, Takahiro Yoshikawa, Miki Takata, Masayasu Kitano, Kiyoshi Matsui, Ran Nakashima, Yuji Hosono, Koichiro Ohmura, Tsuneyo Mimori & Hajime Sano. (2019) Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis. Modern Rheumatology 29:5, pages 814-820.
Read now
Read now
Masahiro Ueki, Ichiro Kobayashi, Shunichiro Takezaki, Yusuke Tozawa, Yuka Okura, Masafumi Yamada, Masataka Kuwana & Tadashi Ariga. (2019) Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Modern Rheumatology 29:2, pages 351-356.
Read now
Read now
Shereen Paramalingam, Peter Counsel, Frank L. Mastaglia, Helen Keen & Merrilee Needham. (2019) Imaging in the diagnosis of idiopathic inflammatory myopathies; indications and utility. Expert Review of Neurotherapeutics 19:2, pages 173-184.
Read now
Read now
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2019) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Modern Rheumatology 29:1, pages 1-19.
Read now
Read now
Takahisa Gono, Yuka Okazaki, Akihiro Murakami & Masataka Kuwana. (2019) Improved quantification of a commercial enzyme-linked immunosorbent assay kit for measuring anti-MDA5 antibody. Modern Rheumatology 29:1, pages 140-145.
Read now
Read now
Ran Nakashima. (2018) Clinical significance of myositis-specific autoantibodies. Immunological Medicine 41:3, pages 103-112.
Read now
Read now
S Hoa, Y Troyanov, MJ Fritzler, IN Targoff, S Chartrand, AM Mansour, E Rich, H Boudabbouz, J Bourré-Tessier, M Albert, JR Goulet, M Landry & JL Senécal. (2018) Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review. Scandinavian Journal of Rheumatology 47:3, pages 210-224.
Read now
Read now
Marie Lecouffe-Desprets, Caroline Hémont, Antoine Néel, Claire Toquet, Agathe Masseau, Mohamed Hamidou, Regis Josien & Jérôme C. Martin. (2018) Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study. Autoimmunity 51:2, pages 89-95.
Read now
Read now
Youhei Fujiki, Takuya Kotani, Kentaro Isoda, Takaaki Ishida, Takeshi Shoda, Shuzo Yoshida, Tohru Takeuchi & Shigeki Makino. (2018) Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Modern Rheumatology 28:1, pages 133-140.
Read now
Read now
V Ortiz-Santamaria, A Babot & C Ferrer. (2017) Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation. Scandinavian Journal of Rheumatology 46:6, pages 509-511.
Read now
Read now
Satoshi Sato, Yoji Uejima, Meika Nanbu, Eisuke Suganuma, Tadamasa Takano, Risa Tanaka, Tomoyuki Kabuki, Eiji Oguma, Tsutomu Oh-Ishi & Yutaka Kawano. (2017) Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis. Modern Rheumatology 27:4, pages 652-656.
Read now
Read now
Yoshiyuki Abe, Naoto Tamura, Shinya Kawano, Souichiro Nakano, Hirofumi Amano, Takayuki Kon, Kurisu Tada, Ken Yamaji & Yoshinari Takasaki. (2017) Detectable anti-MDA5 antibody before onset of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Modern Rheumatology Case Reports 1:2, pages 118-121.
Read now
Read now
Taio Naniwa, Shinya Tamechika, Yuka Okazaki, Shinji Maeda & Masataka Kuwana. (2017) Coexistence of anti-melanoma differentiation-associated gene 5 and anti-aminoacyl-transfer RNA synthetase antibodies in a patient with dermatomyositis and rapidly progressive and relapsing interstitial lung disease. Modern Rheumatology Case Reports 1:1, pages 3-8.
Read now
Read now
Takuya Kotani, Tohru Takeuchi, Yuki Yoshimatsu, Takaaki Ishida, Naomune Yamamoto, Youhei Fujiki, Katsuhiro Oda, Kentaro Isoda, Kenichiro Hata, Takao Kamimori, Hiroshi Fujiwara, Shigeki Makino & Toshiaki Hanafusa. (2016) Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis. Modern Rheumatology 26:5, pages 738-743.
Read now
Read now
Sarah L. Tansley & Neil J. McHugh. (2016) Serological subsets of juvenile idiopathic inflammatory myopathies - an update. Expert Review of Clinical Immunology 12:4, pages 427-437.
Read now
Read now
Albert Selva-O’Callaghan, Ernesto Trallero-Araguás, Maria Angeles Martínez, Moises Labrador-Horrillo, Iago Pinal-Fernández, Josep Maria Grau-Junyent & Candido Juárez. (2015) Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools. Expert Review of Clinical Immunology 11:6, pages 737-747.
Read now
Read now
Articles from other publishers (128)
Masahiro Yasui, Taro Iwamoto & Shunsuke Furuta. (2024) New therapies in anti-MDA5 antibody-positive dermatomyositis. Current Opinion in Rheumatology 36:1, pages 61-68.
Crossref
Crossref
Xin Lu, Qinglin Peng & Guochun Wang. (2023) Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nature Reviews Rheumatology.
Crossref
Crossref
Yida Xing, Changyan Liu, Mingxi Xu, Lin Zhao & Xiaodan Kong. (2023) Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report. Heliyon 9:12, pages e22935.
Crossref
Crossref
Nicole Hartwig Trier & Gunnar Houen. (2023) Antibody Cross-Reactivity in Auto-Immune Diseases. International Journal of Molecular Sciences 24:17, pages 13609.
Crossref
Crossref
Trang T.T. Vu, Kevin K. Brown & Joshua J. Solomon. (2023) Myositis-associated interstitial lung disease. Current Opinion in Pulmonary Medicine 29:5, pages 427-435.
Crossref
Crossref
Yan Wang, Hongxia Jia, Wei Li, Hongping Liu, Meng Tu, Jing Li, Jiuling Cheng & Guojun Zhang. (2023) Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis. Frontiers in Immunology 14.
Crossref
Crossref
Yongxin Mo, Yan Ye, Lisheng Peng, Xiaobo Sun, Xiaofen Zhong & Rui Wu. (2023) The central helicase domain holds the major conformational epitopes of melanoma differentiation–associated gene 5 autoantibodies. Rheumatology.
Crossref
Crossref
Lijun Liu, Yinli Zhang, Cong Wang, Wenjuan Guan, Xin Zhang, Lei Zhang, Yujie He, Wenlu Hu, Shengyun Liu & Tianfang Li. (2023) Ground-glass opacity score predicts the prognosis of anti-MDA5 positive dermatomyositis: a single-centre cohort study. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Jacqueline Jansz, Huynh W Tran & Nadera J Sweiss. (2023) Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT. Cureus.
Crossref
Crossref
Masahiro Kogami, Yoshiyuki Abe, Taiki Ando, Ayako Makiyama, Ken Yamaji & Naoto Tamura. (2023) Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis. Rheumatology 62:7, pages 2525-2533.
Crossref
Crossref
Robert W. Hallowell & Sonye K. Danoff. (2023) Diagnosis and Management of Myositis-Associated Lung Disease. Chest 163:6, pages 1476-1491.
Crossref
Crossref
My Huyen Le, Hoa Thi Dinh, Thu Thi Hoai Le, Phuong Thi Hoang, Minh Nguyet Vu & Doanh Huu Le. (2023) The association between clinical, subclinical features and autoantibody profile in Vietnamese dermatomyositis patients. PLOS Global Public Health 3:1, pages e0000979.
Crossref
Crossref
Chao-Han Liu, Chew-Teng Kor, Ming-Hui Hung, Kai-Hung Hsiao, Yen-Huang Cheng & Ya-Chih Tien. (2023) Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies. Journal of Immunology Research 2023, pages 1-6.
Crossref
Crossref
Noriko Sasaki, Yoko Nakagome, Azusa Kojima, Keigo Shimura, Akira Ishii, Mai Sugiyama, Yuto Izumi, Kazuki Hirano, Takayoshi Kurabayashi, Yuji Hosono, Chiho Yamada & Shinji Sato. (2023) Early Initiation of Plasma Exchange Therapy for Anti-MDA5<sup>+</sup> Dermatomyositis with Refractory Rapidly Progressive Interstitial Lung Disease. Internal Medicine.
Crossref
Crossref
Yue-Tong Xu, Ya-Mei Zhang, Hong-Xia Yang, Li-Fang Ye, Fang Chen, Xin Lu, Guo-Chun Wang & Qing-Lin Peng. (2023) Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease. Rheumatology 62:1, pages 397-406.
Crossref
Crossref
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas De Prost, Antoine Roux, Benjamin Zuber, Dominique Israël Biet, Baptiste Hervier, Abdellatif Tazi, Luc Mouthon, Arsène Mekinian, Christophe Deligny, Raphaël Borie, Jean Claude Meurice, Alain Meyer, Pascaline Priou, Laurent Savale, Luc De Saint Martin, Laure Gallay, Vincent Cottin, Elodie Blanchard, Pierre-Yves Brillet, Philippe Khafagy, Olivier Benveniste, Hilario Nunes, Yves Allenbach & Yurdagül Uzunhan. (2022) Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease. Journal of Autoimmunity 133, pages 102941.
Crossref
Crossref
Natássia Cristina Carboni Truzzi, Leonardo Santos Hoff, Isabela Bruna Pires Borges, Fernando Henrique Carlos de Souza & Samuel Katsuyuki Shinjo. (2022) Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study. Advances in Rheumatology 62:1.
Crossref
Crossref
Xiaomeng Li, Yongmei Liu, Linlin Cheng, Yuan Huang, Songxin Yan, Haolong Li, Haoting Zhan & Yongzhe Li. (2022)
Roles of biomarkers in
anti‐MDA5
‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Kathryn Biddle, Matthew D Taylor, Sarah E Linstead & Patrick D W Kiely. (2022) The Utility of Myositis Specific Antibodies in Clinical Practice. The Journal of Applied Laboratory Medicine 7:5, pages 1189-1201.
Crossref
Crossref
Marissa O’Callaghan, Leah Rooney, Jehangir Khan, Sinead Flanagan, Michael P. Keane, Aurelie Fabre, Lorraine O’Neill & Cormac McCarthy. (2022) A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease. Chest 162:3, pages e111-e116.
Crossref
Crossref
Timothy M. Wilson, Joshua J. Solomon & M. Kristen Demoruelle. (2022) Treatment approach to connective tissue disease-associated interstitial lung disease. Current Opinion in Pharmacology 65, pages 102245.
Crossref
Crossref
Daisuke Hiraoka, Jun Ishizaki, Kenta Horie, Takuya Matsumoto, Koichiro Suemori, Katsuto Takenaka & Hitoshi Hasegawa. (2022) A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy. Modern Rheumatology Case Reports 6:2, pages 194-198.
Crossref
Crossref
Tomohiro Sugimoto, Sho Mokuda, Hiroki Kohno, Michinori Ishitoku, Kei Araki, Hirofumi Watanabe, Tadahiro Tokunaga, Yusuke Yoshida, Shintaro Hirata & Eiji Sugiyama. (2022) Nailfold capillaries and myositis-specific antibodies in anti–melanoma differentiation–associated gene 5 antibody-positive dermatomyositis. Rheumatology 61:5, pages 2006-2015.
Crossref
Crossref
Satoshi Hama, Misako Higashida-Konishi, Mitsuhiro Akiyama, Tatsuya Shimada, Hiroshi Takei, Keisuke Izumi, Hisaji Oshima & Yutaka Okano. (2022) Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy. Internal Medicine 61:7, pages 1085-1091.
Crossref
Crossref
Ichiro Kobayashi, Masaki Shimomura, Masahiro Ueki, Shunichiro Takezaki, Yuka Okura, Mitsuru Nawate, Masafumi Yamada, Yutaka Takahashi & Tadashi Ariga. (2022) Development of Graves’ disease during drug-free remission of juvenile dermatomyositis. Modern Rheumatology Case Reports 6:1, pages 55-58.
Crossref
Crossref
Noriko Arase, Hideaki Tsuji, Hyota Takamatsu, Hui Jin, Hachiro Konaka, Yasuhito Hamaguchi, Kyoko Tonomura, Yorihisa Kotobuki, Ikuko Ueda-Hayakawa, Sumiko Matsuoka, Toru Hirano, Hideki Yorifuji, Hiroyuki Murota, Koichiro Ohmura, Ran Nakashima, Tomoharu Sato, Atsushi Kumanogoh, Ichiro Katayama, Hisashi Arase & Manabu Fujimoto. (2022) Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. Journal of Autoimmunity 126, pages 102774.
Crossref
Crossref
Masaki Shimizu, Natsumi Inoue, Yoshikatsu Takeda, Kensuke Kidouchi, Naohisa Fujita, Toshihiro Fujiki, Asami Takasaki, Yuichi Adachi & Taizo Wada. (2021) Concurrent Treatment With Rituximab and Plasma Exchange for Rapidly Progressive Interstitial Lung Disease Complicating Anti-MDA5 Antibody–Positive Juvenile Dermatomyositis. JCR: Journal of Clinical Rheumatology 27:8S, pages S798-S799.
Crossref
Crossref
Yuichi Yamasaki, Norimoto Kobayashi, Shinji Akioka, Kazuko Yamazaki, Shunichiro Takezaki, Haruna Nakaseko, Asami Ohara, Kenichi Nishimura, Yutaka Nishida, Satoshi Sato, Takayuki Kishi, Motomu Hashimoto, Masaaki Mori, Yuka Okazaki, Masataka Kuwana & Akiko Ohta. (2021) Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study. Rheumatology 60:10, pages 4821-4831.
Crossref
Crossref
Dai Kishida, Satoru Ushiyama, Yasuhiro Shimojima, Ken-ichi Ueno, Jun-ichi Kurashina, Takushi Shirai & Yoshiki Sekijima. (2021) Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody. Internal Medicine 60:16, pages 2697-2700.
Crossref
Crossref
Xianhua Gui, Miao Ma, Jingjing Ding, ShenYun Shi, Xiaoyan Xin, Xiaohua Qiu, Yingwei Zhang, Yuying Qiu, Min Cao, Mei Huang, Mengshu Cao, Jinghong Dai, Hourong Cai & Yonglong Xiao. (2021) Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis. Rheumatology 60:8, pages 3913-3922.
Crossref
Crossref
Anke Rietveld, Judith Wienke, Eline Visser, Wilma Vree Egberts, Wolfgang Schlumberger, Baziel van Engelen, Annet van Royen‐Kerkhof, Hui Lu, Lucy Wedderburn, Christiaan Saris, Sarah Tansley & Ger Pruijn. (2021) Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis. Arthritis & Rheumatology 73:7, pages 1329-1333.
Crossref
Crossref
Gulnara Mamyrova, Takayuki Kishi, Min Shi, Ira N Targoff, Adam M Huber, Rodolfo V Curiel, Frederick W Miller & Lisa G Rider. (2021) Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology 60:4, pages 1839-1849.
Crossref
Crossref
Takahisa Gono, Kenichi Masui, Naoshi Nishina, Yasushi Kawaguchi, Atsushi Kawakami, Kei Ikeda, Yohei Kirino, Yumiko Sugiyama, Yoshinori Tanino, Takahiro Nunokawa, Yuko Kaneko, Shinji Sato, Katsuaki Asakawa, Taro Ukichi, Shinjiro Kaieda, Taio Naniwa, Yutaka Okano & Masataka Kuwana. (2021) Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease. Arthritis & Rheumatology 73:4, pages 677-686.
Crossref
Crossref
T. Shimizu, T. Koga, K. Furukawa, Y. Horai, K. Fujikawa, A. Okada, M. Okamoto, Y. Endo, S. Tsuji, A. Takatani, M. Umeda, S. Fukui, R. Sumiyoshi, S.‐y. Kawashiri, N. Iwamoto, T. Igawa, K. Ichinose, M. Tamai, N. Sakamoto, H. Nakamura, T. Origuchi, H. Mukae, M. Kuwana & A. Kawakami. (2020) IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis. Journal of Internal Medicine 289:2, pages 206-220.
Crossref
Crossref
Masataka Kuwana, Albert Gil-Vila & Albert Selva-O’Callaghan. (2021) Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110324.
Crossref
Crossref
You-Ri Kang, Kun-Hee Kim, Tai-Seung Nam, Kyung-Hwa Lee, Kyung Wook Kang, Seung-Jin Lee, Seok-Yong Choi, Gopalakrishnan Chandrasekaran & Myeong-Kyu Kim. (2020) Fulminant Course of Neuromyelitis Optica in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis: A Case Report. Frontiers in Medicine 7.
Crossref
Crossref
Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello & Elisa Gremese. (2020) What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?. Autoimmunity Reviews 19:11, pages 102666.
Crossref
Crossref
Yukiko Kunitomo, Grant Young, Rupak Datta, Lisa L. Korn, Lynn Tanoue & Samir Gautam. (2020) A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia. Chest 158:4, pages e191-e196.
Crossref
Crossref
Sham Santhanam, Kavitha Mohanasundaram & Shanmuganandan Krishnan. (2020) Interstitial Pneumonia with Autoimmune Features. Journal of the Royal College of Physicians of Edinburgh 50:3, pages 247-255.
Crossref
Crossref
Toyoshi Yanagihara & Yoshikazu Inoue. (2020) Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases. Current Opinion in Pulmonary Medicine 26:5, pages 507-517.
Crossref
Crossref
Akira Yamagata, Machiko Arita, Ayaka Tanaka, Fumiaki Tokioka, Tomohiro Yoshida, Keisuke Nishimura & Tadashi Ishida. (2020)
Therapeutic plasma exchange for clinically amyopathic dermatomyositis (
CADM
) associated with rapidly progressive interstitial pneumonia
. Journal of Clinical Apheresis 35:5, pages 435-443.
Crossref
Crossref
F. Romero-Bueno, P. Diaz del Campo, E. Trallero-Araguás, J.C. Ruiz-Rodríguez, I. Castellvi, M.J. Rodriguez-Nieto, M.J. Martínez-Becerra, O. Sanchez-Pernaute, I. Pinal-Fernandez, X. Solanich, T. Gono, M.A. Gonzalez-Gay, M.N. Plana & A. Selva-O'Callaghan. (2020) Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Seminars in Arthritis and Rheumatism 50:4, pages 776-790.
Crossref
Crossref
Yoshiyuki Abe, Makio Kusaoi, Kurisu Tada, Ken Yamaji & Naoto Tamura. (2020) Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology 59:4, pages 767-771.
Crossref
Crossref
Hideaki Tsuji, Ran Nakashima, Yuji Hosono, Yoshitaka Imura, Masato Yagita, Hajime Yoshifuji, Shintaro Hirata, Takaki Nojima, Eiji Sugiyama, Kazuhiro Hatta, Yoshio Taguchi, Masaki Katayama, Kiminobu Tanizawa, Tomohiro Handa, Ryuji Uozumi, Shuji Akizuki, Kosaku Murakami, Motomu Hashimoto, Masao Tanaka, Koichiro Ohmura & Tsuneyo Mimori. (2020) Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis. Arthritis & Rheumatology 72:3, pages 488-498.
Crossref
Crossref
Hiroyuki Kagawa, Kazuyuki Tsujino, Yuji Yamamoto, Ami Iwai, Reina Hara, Takanori Matsuki, Kiyoharu Fukushima, Yohei Oshitani, Kenji Yoshimura, Mari Miki, Keisuke Miki, Seigo Kitada, Masahide Mori & Hiroshi Kida. (2020) Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report. Respiratory Medicine Case Reports 29, pages 101016.
Crossref
Crossref
Takahisa Gono & Masataka Kuwana. 2020. Managing Myositis. Managing Myositis
193
198
.
Frank Schneider & Patty Chen. 2020. Managing Myositis. Managing Myositis
131
144
.
Ho So & Chi Chiu Mok. (2019) Cyclophosphamide Versus Obinutuzumab for the Treatment of Anti-MDA5 Positive Inflammatory Myopathy with Interstitial Lung Disease: A Study Protocol and Literature Review. Journal of Clinical Rheumatology and Immunology 19:02, pages 53-58.
Crossref
Crossref
Takashi Matsushita, Tadahiro Kobayashi, Miyu Kano, Yasuhito Hamaguchi & Kazuhiko Takehara. (2019) Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease. The Journal of Dermatology 46:12, pages 1190-1196.
Crossref
Crossref
Yanhua Huang & Minhua Mao. (2019) Rapidly Progressive Interstitial Lung Disease Originating from Clinically Amyopathic Dermatomyositis Associated with Positive Anti-MDA 5 Antibody: a Case Report and Literature Review. SN Comprehensive Clinical Medicine 1:11, pages 915-920.
Crossref
Crossref
Yan Ye, Qiong Fu, Ran Wang, Qiang Guo & Chunde Bao. (2019) Serum KL‐6 level is a prognostic marker in patients with anti‐MDA5 antibody‐positive dermatomyositis associated with interstitial lung disease. Journal of Clinical Laboratory Analysis 33:8.
Crossref
Crossref
Haruka Chino, Akimasa Sekine, Tomohisa Baba, Hideya Kitamura, Tae Iwasawa, Koji Okudela, Tamiko Takemura, Harumi Itoh, Shinji Sato, Yasuo Suzuki & Takashi Ogura. (2019) Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity. Internal Medicine 58:18, pages 2605-2613.
Crossref
Crossref
Kathryn Long & Sonye K. Danoff. (2019) Interstitial Lung Disease in Polymyositis and Dermatomyositis. Clinics in Chest Medicine 40:3, pages 561-572.
Crossref
Crossref
Adelle S. Jee & Tamera J. Corte. (2019) Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD). Drugs 79:14, pages 1511-1528.
Crossref
Crossref
Anke Rietveld, Johan Lim, Marianne de Visser, Baziel van Engelen, Ger Pruijn, Olivier Benveniste, Anneke van der Kooi & Christiaan Saris. (2019) Autoantibody testing in idiopathic inflammatory myopathies. Practical Neurology 19:4, pages 284-294.
Crossref
Crossref
Matthew C. Baker, Gideon P. Smith & Eli M. Miloslavsky. (2019) Dermatomyositis Associated With a Skull Base Chondrosarcoma. JCR: Journal of Clinical Rheumatology 25:4, pages e50-e53.
Crossref
Crossref
Lili Jiang, Youlian Wang, Qinglin Peng, Xiaoming Shu, Guochun Wang & Xiaomu Wu. (2019) Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody. Clinical Rheumatology 38:6, pages 1655-1663.
Crossref
Crossref
S.H. Zhang, Y. Zhao, Q.B. Xie, Y. Jiang, Y.K. Wu & B. Yan. (2018) Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti‐melanoma differentiation‐associated gene 5 dermatomyositis. British Journal of Dermatology 180:5, pages 1090-1098.
Crossref
Crossref
Ann Marie Reed, Cynthia S. Crowson & Jeffrey Arthur Dvergsten. (2019) A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy. Frontiers in Immunology 10.
Crossref
Crossref
Haruki Matsumoto, Shuzo Sato, Yuya Fujita, Makiko Yashiro-Furuya, Naoki Matsuoka, Tomoyuki Asano, Hiroko Kobayashi, Hiroshi Watanabe & Kiyoshi Migita. (2019) Rheumatoid Arthritis Complicated with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Interstitial Pneumonia. Internal Medicine 58:5, pages 737-742.
Crossref
Crossref
Takayasu Suzuka, Takuya Kotani, Tohru Takeuchi, Youhei Fujiki, Kenichiro Hata, Shuzo Yoshida, Takeshi Shoda, Shigeki Makino & Shigeki Arawaka. (2018) Efficacy and safety of oral high‐trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis. International Journal of Rheumatic Diseases 22:2, pages 303-313.
Crossref
Crossref
In Seol YooJinhyun Kim. (2019) The Role of Autoantibodies in Idiopathic Inflammatory Myopathies. Journal of Rheumatic Diseases 26:3, pages 165.
Crossref
Crossref
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2018) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Neurology and Clinical Neuroscience 7:1, pages 3-21.
Crossref
Crossref
Hitoshi Kohsaka, Tsuneyo Mimori, Takashi Kanda, Jun Shimizu, Yoshihide Sunada, Manabu Fujimoto, Yasushi Kawaguchi, Masatoshi Jinnin, Yoshinao Muro, Shoichiro Ishihara, Hiroyuki Tomimitsu, Akiko Ohta & Takayuki Sumida. (2018) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. The Journal of Dermatology 46:1.
Crossref
Crossref
Hiroyuki Kamiya, Ogee Mer Panlaqui, Shinyu Izumi & Takashi Sozu. (2018) Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease. BMJ Open 8:12, pages e023998.
Crossref
Crossref
Satoshi Sakamoto, Masaki Okamoto, Shinjiro Kaieda, Kiminori Fujimoto, Shuji Nagata, Masaki Tominaga, Masayuki Nakamura, Yoshiaki Zaizen, Takashi Nouno, Takuma Koga, Tomotaka Kawayama, Masataka Kuwana, Hiroaki Ida & Tomoaki Hoshino. (2018) Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Respiratory Investigation 56:6, pages 464-472.
Crossref
Crossref
Isabela Bruna Pires Borges, Marilda Guimarães Silva & Samuel Katsuyuki Shinjo. (2018) Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis. Anais Brasileiros de Dermatologia 93:4, pages 517-523.
Crossref
Crossref
Mizuki Yagishita, Yuya Kondo, Toshihiko Terasaki, Mayu Terasaki, Masaru Shimizu, Fumika Honda, Ayako Oyama, Hiroyuki Takahashi, Masahiro Yokosawa, Hiromitsu Asashima, Shinya Hagiwara, Hiroto Tsuboi, Isao Matsumoto & Takayuki Sumida. (2018) Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange. Internal Medicine 57:13, pages 1935-1938.
Crossref
Crossref
M. Best, M. Jachiet, N. Molinari, F. Manna, C. Girard, V. Pallure, A. Cosnes, D. Lipsker, T. Hubiche, J.-L. Schmutz, Y. Le Corre, N. Cordel, M. Dandurand, O. Dereure, B. Guillot, A. Du-Thanh, C. Bulai Livideanu, F. Chasset, J.-D. Bouaziz, C. Francès, D. Bengoufa, T. Vincent & D. Bessis. (2018) Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients. Journal of the European Academy of Dermatology and Venereology 32:7, pages 1164-1172.
Crossref
Crossref
Ivan Bogdanov, Jana Kazandjieva, Razvigor Darlenski & Nikolai Tsankov. (2018) Dermatomyositis: Current concepts. Clinics in Dermatology 36:4, pages 450-458.
Crossref
Crossref
Ho So, Victor Tak Lung Wong, Virginia Weng Nga Lao, Hin Ting Pang & Ronald Man Lung Yip. (2018) Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis. Clinical Rheumatology 37:7, pages 1983-1989.
Crossref
Crossref
Juan González-Moreno, Manuel Raya-Cruz, Ines Losada-Lopez, Ana Paula Cacheda, Cristina Oliver & Bartomeu Colom. (2018) Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review. Rheumatology International 38:7, pages 1293-1296.
Crossref
Crossref
Yushiro Endo, Tomohiro Koga, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masataka Kuwana, Yuji Hosono, Tsuneyo Mimori & Atsushi Kawakami. (2018) Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission. Medicine 97:26, pages e11024.
Crossref
Crossref
Ya-Mei Zhang, Han-Bo Yang, Jing-Li Shi, He Chen, Xiao-Ming Shu, Xin Lu, Guo-Chun Wang & Qing-Lin Peng. (2018) The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy. Clinical Rheumatology 37:6, pages 1573-1580.
Crossref
Crossref
Paige W. Wolstencroft & David F. Fiorentino. (2018) Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies. Current Rheumatology Reports 20:5.
Crossref
Crossref
Christopher A. Mecoli & Lisa Christopher-Stine. (2018) Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies. Current Rheumatology Reports 20:5.
Crossref
Crossref
VALÉRIE LECLAIR, ANE LABIRUA-ITURBURU & INGRID E. LUNDBERG. (2018) Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies. The Journal of Rheumatology 45:4, pages 581-583.
Crossref
Crossref
Yushiro Endo, Tomohiro Koga, Takahisa Suzuki, Kazusato Hara, Midori Ishida, Yuya Fujita, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Takashi Igawa, Masataka Umeda, Shoichi Fukui, Ayako Nishino, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Masataka Kuwana & Atsushi Kawakami. (2018) Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Medicine 97:15, pages e0436.
Crossref
Crossref
Drew J.B. Kurtzman & Ruth Ann Vleugels. (2018) Anti-melanoma differentiation–associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. Journal of the American Academy of Dermatology 78:4, pages 776-785.
Crossref
Crossref
Miki Takata, Akira Yamasaki, Nanako Yamada, Hiroshi Hagino, Yoshihiro Funaki, Tomoya Harada, Ryota Okazaki, Yasuyuki Hasegawa, Takehito Fukushima, Masato Morita, Yuriko Sueda, Akihiro Yamamoto & Eiji Shimizu. (2018) A case of clinically amyopathic dermatomyositis that developed during anti-TNF-α therapy for rheumatoid arthritis. Allergology International 67:2, pages 286-288.
Crossref
Crossref
Makiko Yashiro, Tomoyuki Asano, Shuzo Sato, Hiroko Kobayashi, Hiroshi Watanabe, Masayuki Miyata & Kiyoshi Migita. (2018) Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 64:2, pages 89-94.
Crossref
Crossref
Takeshi Osawa, Kozo Morimoto, Yuka Sasaki, Shuichi Matsuda, Kazunari Yamana, Ryozo Yano, Takashi Uchiyama & Hajime Goto. (2018) The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level. Internal Medicine 57:3, pages 387-391.
Crossref
Crossref
Fang Chen, Shanshan Li, Tao Wang, Jingli Shi & Guochun Wang. (2018) Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies. The American Journal of the Medical Sciences 355:1, pages 48-53.
Crossref
Crossref
Hiroko Okabayashi, Hidenori Ichiyasu, Sayuri Hirooka, Kimitaka Akaike, Keisuke Kojima, Takayuki Jodai, Yasumiko Sakamoto, Hideharu Ideguchi, Shohei Hamada, Chieko Yoshida, Susumu Hirosako, Shinichiro Okamoto & Hirotsugu Kohrogi. (2017) Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
JM Lin, YB Zhang, QL Peng, HB Yang, JL Shi, ML Gu, WM Zhao & GC Wang. (2017) Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population. HLA 90:6, pages 354-359.
Crossref
Crossref
Rochelle Castillo & Jemima Albayda. (2017) Dermatomyositis: Autoantibodies and Their Corresponding Phenotypes. Current Treatment Options in Rheumatology 3:4, pages 254-266.
Crossref
Crossref
H. Koguchi‐Yoshioka, N. Okiyama, K. Iwamoto, Y. Matsumura, T. Ogawa, S. Inoue, R. Watanabe & M. Fujimoto. (2017) Intravenous immunoglobulin contributes to the control of antimelanoma differentiation‐associated protein 5 antibody‐associated dermatomyositis with palmar violaceous macules/papules. British Journal of Dermatology 177:5, pages 1442-1446.
Crossref
Crossref
B. Garcia, F. Dabouz, L. Pascal, M. Gillard & P. Modiano. (2017) Dermatomyosite amyopathique avec anticorps anti-MDA-5, associée à une pemphigoïde bulleuse, un syndrome de Sjögren et un lymphome de type MALT. Annales de Dermatologie et de Vénéréologie 144:10, pages 629-633.
Crossref
Crossref
Yoshiyuki Abe, Masakazu Matsushita, Kurisu Tada, Ken Yamaji, Yoshinari Takasaki & Naoto Tamura. (2017) Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody–positive inflammatory myositis. Rheumatology 56:9, pages 1492-1497.
Crossref
Crossref
Adelle Jee, Stephen Adelstein, Jane Bleasel, Gregory Keir, MaiAnh Nguyen, Joanne Sahhar, Peter Youssef & Tamera Corte. (2017) Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine 6:5, pages 51.
Crossref
Crossref
Margherita Milone. (2017) Diagnosis and Management of Immune-Mediated Myopathies. Mayo Clinic Proceedings 92:5, pages 826-837.
Crossref
Crossref
T. Matsushita, K. Mizumaki, M. Kano, N. Yagi, M. Tennichi, A. Takeuchi, Y. Okamoto, Y. Hamaguchi, A. Murakami, M. Hasegawa, M. Kuwana, M. Fujimoto & K. Takehara. (2017) Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. British Journal of Dermatology 176:2, pages 395-402.
Crossref
Crossref
Harsha Gunawardena. (2015) The Clinical Features of Myositis-Associated Autoantibodies: a Review. Clinical Reviews in Allergy & Immunology 52:1, pages 45-57.
Crossref
Crossref
Minoru Satoh, Shin Tanaka, Angela Ceribelli, S. John Calise & Edward K. L. Chan. (2015) A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. Clinical Reviews in Allergy & Immunology 52:1, pages 1-19.
Crossref
Crossref
Yuki Sato, Kojiro Otsuka, Koji Tamai, Yuichiro Ono, Yasuhito Hamaguchi & Keisuke Tomii. (2017) An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years. Internal Medicine 56:3, pages 341-346.
Crossref
Crossref
Olivier Benveniste, Werner Stenzel & Yves Allenbach. (2016) Advances in serological diagnostics of inflammatory myopathies. Current Opinion in Neurology 29:5, pages 662-673.
Crossref
Crossref
Bornstein Gil, Lidar Merav, Langevitz Pnina & Grossman Chagai. (2015) Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review. Clinical Rheumatology 35:8, pages 2125-2130.
Crossref
Crossref
R Nakashima, Y Hosono & T Mimori. (2016) Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25:8, pages 925-933.
Crossref
Crossref
Z. Betteridge & N. McHugh. (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. Journal of Internal Medicine 280:1, pages 8-23.
Crossref
Crossref
Nicole Fabien. (2016) Anticorps des myopathies autoimmunes : actualités des techniques de détection et intérêt clinique. Revue Francophone des Laboratoires 2016:484, pages 41-46.
Crossref
Crossref
David F Fiorentino, Matthew Presby, Alan N Baer, Michelle Petri, Kerri E Rieger, Mark Soloski, Antony Rosen, Andrew L Mammen, Lisa Christopher-Stine & Livia Casciola-Rosen. (2016) PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome. Annals of the Rheumatic Diseases 75:6, pages 1145-1151.
Crossref
Crossref
Shinji Sato, Akihiro Murakami, Akiko Kuwajima, Kazuhiko Takehara, Tsuneyo Mimori, Atsushi Kawakami, Michiaki Mishima, Takafumi Suda, Mariko Seishima, Manabu Fujimoto & Masataka Kuwana. (2016) Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies. PLOS ONE 11:4, pages e0154285.
Crossref
Crossref
Thomas Bahmer, Micaela Romagnoli, Francesco Girelli, Martin Claussen & Klaus F. Rabe. (2016) The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist. Respiratory Medicine 113, pages 80-92.
Crossref
Crossref
Yasuhito HAMAGUCHI. (2016) Autoantibodies and Their Clinical Characteristics in Dermatomyositis/Polymyositis. Nishi Nihon Hifuka 78:5, pages 463-467.
Crossref
Crossref
Atsushi Suzuki, Yasuhiro Kondoh, Hiroyuki Taniguchi, Kazuhiko Tabata, Tomoki Kimura, Kensuke Kataoka, Kenzo Ono, Mikiko Hashisako & Junya Fukuoka. (2016) Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis. Respiratory Medicine Case Reports 19, pages 5-8.
Crossref
Crossref
Norimoto Kobayashi, Ichiro Kobayashi, Masaaki Mori, Shinji Sato, Naomi Iwata, Tomonari Shigemura, Kazunaga Agematsu, Shumpei Yokota & Kenichi Koike. (2015) Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis. The Journal of Rheumatology 42:12, pages 2412-2418.
Crossref
Crossref
Satoshi Ikeda, Machiko Arita, Kenta Misaki, Shohei Mishima, Takuya Takaiwa, Akihiro Nishiyama, Akihiro Ito, Kenjiro Furuta, Toshihide Yokoyama, Fumiaki Tokioka, Maki Noyama, Hiroshige Yoshioka & Tadashi Ishida. (2015) Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. SpringerPlus 4:1.
Crossref
Crossref
Paola Parronchi, Anna Radice, Boaz Palterer, Francesco Liotta & Cristina Scaletti. (2015) MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations. Clinical and Molecular Allergy 13:1.
Crossref
Crossref
Takuya Kotani, Tohru Takeuchi, Takaaki Ishida, Ryota Masutani, Kentaro Isoda, Kenichiro Hata, Shuzo Yoshida, Shigeki Makino & Toshiaki Hanafusa. (2015) Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study. PLOS ONE 10:10, pages e0140117.
Crossref
Crossref
Toshinori Takada, Ami Aoki, Katsuaki Asakawa, Takuro Sakagami, Hiroshi Moriyama, Ichiei Narita & Shinji Sato. (2015) Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis. Respiratory Medicine 109:9, pages 1174-1180.
Crossref
Crossref
Shinji Sato & Masataka Kuwana. (2015) Utility of dermatomyositis-specific autoantibodies for diagnosis and clinical subsetting. International Journal of Clinical Rheumatology 10:4, pages 257-271.
Crossref
Crossref
B. Volc-Platzer. (2015) Dermatomyositis – updateDermatomyositis—update. Der Hautarzt 66:8, pages 604-610.
Crossref
Crossref
Bregje Jaeger, Marianne de Visser, Eleonora Aronica & Anneke J. van der Kooi. (2015) Respiratory failure as presenting symptom of necrotizing autoimmune myopathy with anti-melanoma differentiation-associated gene 5 antibodies. Neuromuscular Disorders 25:6, pages 457-460.
Crossref
Crossref
N. Kobayashi, S. Takezaki, I. Kobayashi, N. Iwata, M. Mori, K. Nagai, N. Nakano, M. Miyoshi, N. Kinjo, T. Murata, K. Masunaga, H. Umebayashi, T. Imagawa, K. Agematsu, S. Sato, M. Kuwana, M. Yamada, S. Takei, S. Yokota, K. Koike & T. Ariga. (2014) Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology 54:5, pages 784-791.
Crossref
Crossref
David Delman, Xianming Peng, Daniel C. Zedek, Valerie Jewells, Nizar Chahin & Silva Markovic-Plese. (2015) Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder. Journal of Neuroimmunology 278, pages 108-111.
Crossref
Crossref
Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, Zoe Betteridge, Lászlóné Szöllősi & Katalin Dankó. (2014) Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmunity Reviews 13:12, pages 1211-1219.
Crossref
Crossref
Maren Breithaupt & Jens Schmidt. (2014) Diagnostik und Therapie von Myositiden. NeuroTransmitter 25:12, pages 46-56.
Crossref
Crossref
Simon Rothwell, Robert G. Cooper, Janine A. Lamb & Hector Chinoy. (2014) Strategies for Evaluating Idiopathic Inflammatory Myopathy Disease Susceptibility Genes. Current Rheumatology Reports 16:10.
Crossref
Crossref
I. Pau-Charles, P.J. Moreno, K. Ortiz-Ibáñez, M.C. Lucero, A. Garcia-Herrera, G. Espinosa, J.M. Nicolás, P. Castro, J.M. Grau, L. Casciola-Rosen & J.M. MascaróJrJr. (2014) Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy. Journal of the European Academy of Dermatology and Venereology 28:8, pages 1097-1102.
Crossref
Crossref
Tomoyuki Fujisawa, Hironao Hozumi, Masato Kono, Noriyuki Enomoto, Dai Hashimoto, Yutaro Nakamura, Naoki Inui, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Toshihiro Shirai, Kazumasa Yasuda, Hiroshi Hayakawa & Takafumi Suda. (2014) Prognostic Factors for Myositis-Associated Interstitial Lung Disease. PLoS ONE 9:6, pages e98824.
Crossref
Crossref
Theresa Canavan, Tivon Sidorsky, Linda T. Doan, Roberto R. Ricardo-Gonzalez, Guoqiu Shen & Michael D. Rosenblum. (2014) A case of Wong-type dermatomyositis with concomitant anti-MDA5 features. Journal of the American Academy of Dermatology 70:3, pages e62-e64.
Crossref
Crossref
P -O Carstens & J Schmidt. (2014) Diagnosis, pathogenesis and treatment of myositis: recent advances. Clinical and Experimental Immunology 175:3, pages 349-358.
Crossref
Crossref
Kenta Sato, Saori Morozumi, Yuko Takeuchi, Jun Ochiai & Chiyuki Mabuchi. (2014) A case of dermatomyositis with anti-CADM-140 antibody and alveolar hemorrhage. Rinsho Shinkeigaku 54:5, pages 408-412.
Crossref
Crossref
Ran Nakashima. (2014) 4. Polymyositis and Dermatomyositis. Nihon Naika Gakkai Zasshi 103:10, pages 2487-2491.
Crossref
Crossref
Koji Tamai, Ryo Tachikawa, Kyoko Otsuka, Hiroyuki Ueda, Yuji Hosono & Keisuke Tomii. (2014) Early Pulmonary Involvement of Anti-CADM-140 Autoantibody-positive Rapidly Progressive Interstitial Lung Disease Preceding Typical Cutaneous Symptoms. Internal Medicine 53:21, pages 2515-2519.
Crossref
Crossref
Aoi Teruya, Kodai Kawamura, Kazuya Ichikado, Shinji Sato, Yuko Yasuda & Masakazu Yoshioka. (2013) Successful Polymyxin B Hemoperfusion Treatment Associated With Serial Reduction of Serum Anti-CADM-140/MDA5 Antibody Levels in Rapidly Progressive Interstitial Lung Disease With Amyopathic Dermatomyositis. Chest 144:6, pages 1934-1936.
Crossref
Crossref
Simon Rothwell, Robert G. Cooper, Janine A. Lamb & Hector Chinoy. (2013) Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies. Current Opinion in Rheumatology 25:6, pages 735-741.
Crossref
Crossref
Imen Zamali, Zeineb Meddeb, Dorra Bejar, Fatma Korbi, Ahlem Ben Hmid, Thara Laarbi, Mouldi Hidri, Kamel Bousslama & Melika Ben Ahmed. (2022) Diagnostic Challenge of Anti-MDA5 Myositis with Respiratory Failure During COVID-19 Pandemic. SSRN Electronic Journal.
Crossref
Crossref